Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography
Author
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-12-22
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Abstract EN
The use of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for response assessment in lymphoma is now widespread.
Prognostic information obtained from PET performed after two to three cycles of chemotherapy may guide more individualized, risk-adapted therapeutic strategies.
Progress in the risk stratification of Hodgkin's lymphoma through midtreatment PET is reviewed, with a focus on management implications in newly diagnosed and relapsed disease.
How to tailor treatment on the basis of the interim PET result is not yet defined but is the subject of ongoing trials.
American Psychological Association (APA)
Kasamon, Yvette L.. 2010. Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography. Advances in Hematology،Vol. 2011, no. 2011, pp.1-12.
https://search.emarefa.net/detail/BIM-459214
Modern Language Association (MLA)
Kasamon, Yvette L.. Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography. Advances in Hematology No. 2011 (2011), pp.1-12.
https://search.emarefa.net/detail/BIM-459214
American Medical Association (AMA)
Kasamon, Yvette L.. Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography. Advances in Hematology. 2010. Vol. 2011, no. 2011, pp.1-12.
https://search.emarefa.net/detail/BIM-459214
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-459214
